Ansa is accepting orders for synthetic DNA constructs ranging from 7.5 kb up to 50 kb for various applications.

Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...

The virus likely reached humans not via bat migration but through the wildlife trade—contradicting hypotheses that it may ...

Researchers use generative AI to design synthetic enhancers that can effectively control gene expression in healthy mammalian ...

Lipid receptor SR-B1 identified as a potential immunotherapy target to boost NK cell antitumor response in advanced ovarian ...

Researchers headed by a team at the California Institute of Technology developed an ultrasound-guided 3D printing technique ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T ...

Researchers expect LICONN technology will be broadly useful to enable high-resolution tissue analysis in other organs and ...

Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly ...

We talk about news in cancer, updates on COVID's origin, and business news in biotech in this episode of Touching Base.

From connectors and containers to plasmids and platforms, companies work to get these treatments to patients faster and more ...

Low blood sugar contributes to eye damage and vision loss in diabetic retinopathy; an experimental drug may help treat the ...